Cassandra Salgado to Vancomycin Resistance
This is a "connection" page, showing publications Cassandra Salgado has written about Vancomycin Resistance.
Connection Strength
1.547
-
The risk of developing a vancomycin-resistant Enterococcus bloodstream infection for colonized patients. Am J Infect Control. 2008 Dec; 36(10):S175.e5-8.
Score: 0.314
-
Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE. Infect Control Hosp Epidemiol. 2008 May; 29(5):404-9.
Score: 0.301
-
Should clinicians worry about vancomycin-resistant Enterococcus bloodstream infections? Bone Marrow Transplant. 2006 Dec; 38(12):771-4.
Score: 0.273
-
Failure to develop vancomycin-resistant Enterococcus with oral vancomycin treatment of Clostridium difficile. Infect Control Hosp Epidemiol. 2004 May; 25(5):413-7.
Score: 0.228
-
Outcomes associated with vancomycin-resistant enterococci: a meta-analysis. Infect Control Hosp Epidemiol. 2003 Sep; 24(9):690-8.
Score: 0.218
-
Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unit. Infect Control Hosp Epidemiol. 2013 May; 34(5):479-86.
Score: 0.107
-
Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers. Ann Pharmacother. 2008 Mar; 42(3):317-26.
Score: 0.074
-
Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper . Infect Control Hosp Epidemiol. 2008 Oct; 29(10):901-13.
Score: 0.019
-
Can antibiotic-resistant nosocomial infections be controlled? Lancet Infect Dis. 2001 Aug; 1(1):38-45.
Score: 0.012